USD 1.07 billion
Global Influenza Diagnostics Market Size, Share, Growth Analysis, By Test Type(Traditional Diagnostic Test, Molecular Diagnostic Assay), By End-User(Hospital, Laboratories) - Industry Forecast 2024-2031
Report ID:
SQSG35G2011 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|
Tables:
62 |
Figures:
75
Global Influenza Diagnostics Market Insights
Influenza Diagnostics Market size was valued at USD 1.07 billion in 2019 and is poised to grow from USD 1.1 billion in 2023 to USD 1.46 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024-2031).
Influenza is simply referred to as the flu. It is an infectious disease of the upper respiratory tract caused by the influenza virus. The seasonal influenza virus is classified into three types: Influenza B, Influenza A, And Influenza C, which are characterized by two major surface proteins: hemagglutinin (HA) and neuraminidase (NA). Different serotypes are observed as a result of differences in these surface proteins, which determine the antibody response to the viruses. Because influenza is a highly contagious and communicable disease, infected patients who serve as carriers of the disease can easily transmit the disease in public places.
The disease burden varies by region, with temperate climate regions experiencing seasonal influenza outbreaks. In tropical regions where influenza occurs all year, causing constant outbreaks, disease management and treatment are difficult. Rising demand for rapid disease diagnosis, rising influenza prevalence, and increased influenza research for diagnostic technologies are driving the Influenza Diagnostics Market growth.
US Influenza Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Traditional Diagnostic Test
Fastest Growth
Traditional Diagnostic Test
Growth Rate
3.5% CAGR
Global Influenza Diagnostics Market, 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
Global Influenza Diagnostics Market Size By Test Type, 2021-2028 ($ Bn)
Global Influenza Diagnostics Market Size By Test Type, 2021-2028 (%)
To get more reports on the above market click here to Buy The Report
Global Influenza Diagnostics Market Segmental Analysis
The Global Influenza Diagnostics Market is segmented based on Test Type, End-User, and Region. Based on Test Type it is categorized into Traditional Diagnostic Test and Molecular Diagnostic Assay. The Traditional Diagnostic Test segment is further bifurcated into RIDT, Viral Culture, Direct Fluorescent Antibody (DFA) Test, and Serological Assay. Molecular Diagnostic Assay is sub-segmented into RT-PCR, Nucleic Acid Sequence-based Amplification (NASBA) Test, Loop-mediated Isothermal Amplification-based Assay (LAMP), Simple Amplification-based Assay (SAMBA), and Other Molecular Diagnostic Assays. By End User, the Influenza Diagnostics Market studied is segmented into hospitals, Laboratories, and Other End Users. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
Influenza Diagnostics Market Analysis by Test Type
In 2022, the rapid influenza diagnostic test (RIDT) is anticipated to hold the largest market share in the test type segment of the influenza diagnostics market, out of all traditional diagnostic tests. Rapid influenza diagnostic tests (RIDTs) are immunoassays that detect and provide qualitative results for influenza A and B viral nucleoprotein antigens in respiratory specimens. It is capable of diagnosing patients with influenza-like illness, particularly if performed within the first four days of symptoms appearing. RIDT's popularity is driven by the benefits of faster results and ease of use. Some RIDTs are also approved for use in the office or at the patient's bedside. The RIDT segment is also expected to grow rapidly due to its widespread use in point-of-care settings.
Influenza Diagnostics Market Analysis by End-user
The diagnostic laboratories segment dominated the influenza diagnostics market in 2021. The rising prevalence of influenza, as well as the growing demand for rapid disease diagnosis, are driving the growth of this segment
Global Influenza Diagnostics Market By Test Type, 2021 (%), 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Influenza Diagnostics Market Regional Insights
In 2021, North America dominated the influenza diagnostics market and it is expected to maintain its dominance throughout the forecast period (2022-2028). The regional Influenza Diagnostics Market is expected to be driven by the high prevalence of influenza during the forecast period. It is estimated that, approximately 5% to 20% of Americans will be diagnosed with influenza each year in 2022. Moreover, the Centers for Disease Control and Prevention reported 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related deaths, and 16 million flu-related medical visits in 2019-2020. This rising disease burden is believed to have a positive impact on market growth in the coming years. RIDTs are widely available all across the region. The short time required to generate results is the reason for the test's wider availability. RIDT can produce results in as little as 15 minutes. With rising influenza-related hospitalizations and pediatric deaths, as well as government organizations' desire to better manage the disease, the North American influenza diagnostics market is expected to expand in the coming years.
Furthermore, the Asia Pacific region is expected to grow at a rapid pace. Adoption of new technology and increased public awareness are expected to be the factors propelling the market growth. Human infection with avian influenza A (H5NI), which resulted in an influenza pandemic, is one of the most concerning aspects of influenza in Asia. There is a growing concern, and countries are actively involved in taking preventive measures to combat the disease's spread.
Global Influenza Diagnostics Market By Geography, 2021-2028, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Influenza Diagnostics Market Dynamics
Influenza Diagnostics Market Driver
- The Human Genome Project and advances in molecular and biomedical technologies have resulted in the development of a plethora of assays and technologies useful for the diagnosis and management of influenza infections. These new technologies, which are based on genomic techniques (such as PCR) and proteomics (such as microarray detection), aid in the discovery of new influenza viruses. They also allow for better surveillance and rapid diagnosis of infectious diseases, which offers a Influenza Diagnostics Market opportunity.
- Geriatrics are vulnerable to a wide range of diseases because their immune systems are weakened, and they are at a high risk of contracting influenza. Individuals with weakened immune systems, such as those suffering from a chronic disease, are also vulnerable to the disease. As a result of an increasing number of people being susceptible to the disease, demand for influenza diagnostics products has increased, fueling the Influenza Diagnostics Market growth.
- The increasing global prevalence of influenza has increased R&D efforts toward effective detection and diagnosis. The majority of research activity is directed toward developing faster and more accurate diagnostic solutions for influenza viruses, which will lead to Influenza Diagnostics Market growth.
Influenza Diagnostics Market Restraint
- The main factors influencing the results of influenza diagnostic tests are sensitivity and specificity. The antigenic variation of influenza viruses is the primary cause of the tests' complexity. As a result, there are variations in the sensitivity and specificity of influenza diagnostic tests, which can affect the final test results. False-negative results are more common than false-positive results as a result of this factor, especially during peak influenza season, which is a factor that restricts the growth of the influenza diagnostics market.
Request Free Customization of this report to help us to meet your business objectives.
Global Influenza Diagnostics Market Competitive Landscape
The Influenza Diagnostics Market is highly competitive, with the existence of numerous major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve market share and profitability. Some of the major players in the market are Becton Dickinson, Biomerieux, Merck, and Bio-Rad Laboratories among others who are driving the Influenza Diagnostics Market.
Influenza Diagnostics Market Top Player’s Company Profiles
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
- Abbott Laboratories
- Becton, Dickinson and Company
- Quidel Corporation
- DiaSorin S.p.A.
- bioMérieux SA
- Meridian Bioscience, Inc.
- Luminex Corporation
- Hologic, Inc.
- F. Hoffmann-La Roche Ltd.
- Cepheid Inc.
- Sekisui Diagnostics LLC
- GenMark Diagnostics, Inc.
- Quanterix Corporation
- Alere Inc.
- Merck KGaA
- Hologic, Inc.
- Scienion AG
- Enzo Biochem, Inc.
Influenza Diagnostics Market Recent Developments
- In May 2022, The American pharmaceutical company announced that it has obtained Nod from the USFDA for the drug Aptima CMV Quant Assay for human cytomegalovirus. Use. And this could be a great development in reducing the adverse effect of the virus on humans.
- In February 2022, Siemens Healthineers, in partnership with United Nations Children's Fund, today announced its contribution to strengthening health systems in the various African region by improving access to diagnostics and the link to treatment of major diseases.
- In September 2021, Simplexa COVID-19 & Flu A/B Direct kit from DiaSorin Molecular LLC received the CE mark. The multiplex test allows for the in vitro qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, and influenza B virus from the same patient sample in a single reaction well.
Global Influenza Diagnostics Key Market Trends
- Vaccination is a major method of immunizing individuals against infectious diseases to avoid serious complications, particularly in immunocompromised patients who are at high risk. Mutation of the virus serotype proves to be a major impediment because vaccination becomes difficult in such cases, putting the individual at risk of contracting the virus. Thus, as virus types change, it is critical to detect their presence in patients and administer timely medication to prevent fatalities. As a result, the demand for influenza diagnostics products has increased, accelerating market growth.
- The rising geriatric population, broadening government anti-influenza initiatives, rising prevalence of chronic diseases such as diabetes, heart and blood disorders, and the emergence of technologically advanced influenza diagnostic tests are some of the key factors driving the influenza diagnostics market's growth.
- Pregnant women, children, the elderly, immunocompromised patients with chronic medical conditions, and healthcare workers are at high risk of contracting influenza. The treatment for influenza consists of a variety of antiviral drugs that help to reduce complications and fatalities such as death. Antiviral drugs used conventionally are ineffective in the majority of patients due to drug resistance. As a result, the development of vaccines and drugs has seen an increase in demand, assisting developers in the industry.
Global Influenza Diagnostics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, the increasing prevalence of influenza and related chronic diseases, increased research and development activities in influenza diagnostics technologies, growing awareness for early detection using specific diagnostic tests, and other factors are driving the Global Influenza Diagnostics Market. However, the rising cost of influenza diagnostic kits and reagents is the primary impediment to Influenza Diagnostics Market growth. Furthermore, variability in sensitivity and specificity among influenza diagnostic tests, as well as the presence of a complex regulatory framework for the approval of new diagnostic tests, are expected to limit market growth to some extent.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.07 billion |
| Market size value in 2031 | USD 1.46 billion |
| Growth Rate | 3.5% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
| Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Influenza Diagnostics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Influenza Diagnostics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Influenza Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Influenza Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Influenza Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Influenza Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Influenza Diagnostics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
